The Global Corporate Venturing deal net rounds up the smaller investments from across the corporate innovation ecosystem.

Web3 services provider Venly and genomic analysis technology provider Genome Insight each raised $23m while Rui Ye Lian helped Cedarlake Capital close a $189m fund.

Content personalisation technology provider Movable Ink and carbon-negative concrete developer Brimstone each raised $55m, with Intel and Amazon respectively among the investors.

Call centre software producer Replicant closed a $78m series B round backed by Salesforce Ventures while Ashvattha Therapeutics raised $69m from investors including strategic partner Huadong Medicine.

Corporate-backed medical imaging technology producer Lunit is preparing to float in South Korea while cancer drug developer Pheast secured $76m from investors including Alexandria Venture Investments.

Yangtze River Pharmaceutical Group led Binhui Biopharm's $47m series B-plus round while Sigfox has been snapped up by UnaBiz for under $30m after raising over $300m.

Web3 security software producer Certik received $60m from investors including SoftBank Vision Fund 2 while corporate-backed automation technology provider Vicarious is being bought after raising over $250m.

Appliance management app developer Fresco's $20m round was co-led by Vorwerk and Instant Brands while NBCUniversal and Hearst helped media measurement software provider TVScientific raise $20m.

SK Hynix, Marvell and M12 helped data centre technology producer D-Matrix pull in $44m while health insurance provider SafetyWing raised $35m from investors including Digital Garage and CreditEase.

Citi Ventures, Salesforce Ventures and Telstra Ventures all invested in blockchain infrastructure provider Blockdaemon's series D round while GV backed cybersecurity software provider Obsidian's $90m series C.